Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tichler

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Clinical Trials|January 1, 1979
"CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinomaT Lad, P R Sarma, U Diekamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposideB Sredni, M Albeck, T Tichler, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Immunologic effects of AS101 in the treatment of cancer patientsA Shani, T Tichler, R Catane, et al.
Cancer Treatment Reports|November 1, 1981
Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trialT E Lad, R B Nelson, U Diekamp, et al.
International Journal of Cancer|January 3, 1996
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal modelsB Sredni, R H Xu, M Albeck, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Clinical Trials|January 1, 1979
"CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinomaT Lad, P R Sarma, U Diekamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposideB Sredni, M Albeck, T Tichler, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Immunologic effects of AS101 in the treatment of cancer patientsA Shani, T Tichler, R Catane, et al.
Cancer Treatment Reports|November 1, 1981
Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trialT E Lad, R B Nelson, U Diekamp, et al.
International Journal of Cancer|January 3, 1996
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal modelsB Sredni, R H Xu, M Albeck, et al.
Pageof 2